0001209191-15-018691.txt : 20150225
0001209191-15-018691.hdr.sgml : 20150225
20150225172918
ACCESSION NUMBER: 0001209191-15-018691
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150223
FILED AS OF DATE: 20150225
DATE AS OF CHANGE: 20150225
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daly James M
CENTRAL INDEX KEY: 0001560782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 15649084
MAIL ADDRESS:
STREET 1: INCYTE CORPORATION EXPERIMENTAL STATION
STREET 2: RTE 141 & HENRY CLAY RD. BLDG E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-02-23
0
0000879169
INCYTE CORP
INCY
0001560782
Daly James M
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP, Chief Commercial Officer
Common Stock
2015-02-23
4
M
0
2778
18.32
A
6299
D
Common Stock
2015-02-23
4
S
0
2778
83.44
D
3521
D
Common Stock
2015-02-24
4
M
0
7732
16.62
A
11253
D
Common Stock
2015-02-24
4
M
0
602
16.62
A
11855
D
Common Stock
2015-02-24
4
S
0
8334
81.77
D
3521
D
Non-Qualified Stock Option (right to buy)
18.32
2015-02-23
4
M
0
2778
0.00
D
2020-02-08
Common Stock
2778
27877
D
Non-Qualified Stock Option (right to buy)
16.62
2015-02-24
4
M
0
7732
0.00
D
2019-10-21
Common Stock
7732
61855
D
Non-Qualified Stock Option (right to buy)
16.62
2015-02-24
4
M
0
602
0.00
D
2019-10-21
Common Stock
602
4813
D
Represents weighted average sale price. Actual sale prices ranged from $82.79 - $83.58.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
Represents weighted average sale price. Actual sale prices ranged from $80.73 - $83.39.
Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning October 22, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
/s/ James M. Daly
2015-02-25